Profiles: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Technically Confirmed Profiles=== | ===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Technically Confirmed Profiles=== | ||
* [[Media: | * [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]] | ||
===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 2]]: Consensus Profiles=== | ===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 2]]: Consensus Profiles=== | ||
Revision as of 02:13, 4 January 2017
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed Profiles
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committees may link to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)